Literature DB >> 7069224

Tri-state toxic-shock syndrome study. II. Clinical and laboratory findings.

J P Davis, M T Osterholm, C M Helms, J M Vergeront, L A Wintermeyer, J C Forfang, L A Judy, J Rondeau, W L Schell.   

Abstract

Clinical and laboratory findings were examined in 80 nonfatal cases of toxic-shock syndrome (TSS) which occurred in women from Minnesota, Wisconsin, and Iowa between October 1, 1979, and September 19, 1980. Among the clinical and laboratory factors reviewed, the presence of physician-diagnosed shock was the factor that most significantly correlated with other organ involvement. Vomiting, mucous membrane hyperemia, myalgias, and abnormal urinalysis were the factors noted to be manifest as frequently in the absence as in the presence of shock. Twenty-seven patients had recurrent episodes of TSS. The use of antistaphylococcal antibiotics during the initial TSS episode and the subsequent discontinuation of tampon use were independently statistically significantly associated with a decreased risk of recurrent illness. Only 44 of 54 patients had cervical/vaginal cultures positive for Staphylococcus aureus, a result indicating that a negative cervical/vaginal culture does not preclude the diagnosis of TSS.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069224     DOI: 10.1093/infdis/145.4.441

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Therapy of toxic shock syndrome.

Authors:  J K Todd
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

2.  Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.

Authors:  Patrick M Schlievert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

Review 3.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 4.  Toxic shock syndrome: a review of the literature.

Authors:  D Thomas; P S Withington
Journal:  Ann R Coll Surg Engl       Date:  1985-05       Impact factor: 1.891

Review 5.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

6.  Studies on staphylococci from toxic shock syndrome in France, 1981-1983.

Authors:  A K Melconian; J Fleurette; Y Brun
Journal:  J Hyg (Lond)       Date:  1985-02

7.  Toxic shock syndrome: clinical and laboratory findings in 30 patients.

Authors:  A W Chow; C K Wong; A M MacFarlane; K H Bartlett
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

Review 8.  Toxic-shock syndrome: a commentary and review of the characteristics of Staphylococcus aureus strains.

Authors:  P J Chesney
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

Review 9.  Rapidly fatal infections.

Authors:  Diana Hans; Erin Kelly; Krista Wilhelmson; Eric D Katz
Journal:  Emerg Med Clin North Am       Date:  2008-05       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.